1 |
0.1% DMSO, 1hr |
Ligand, 10 μM |
Positive control, agonism |
2 |
10 μM Ligand, 1hr |
Epinephrine, 5 nM |
Specificity, relative potency and efficacy, modes of action |
3 |
1 μM propranolol, 1hr |
Ligand, 10 μM |
Specificity, relative potency and efficacy, modes of action |
4 |
5 nM Epinephrine, 1hr |
Ligand, 10 μM |
Receptor desensitization and deactivation |
5 |
10 μM ligand, 5hr |
Epinephrine, 5nM |
Kinetics dependent receptor blockage by antagonists and receptor desensitization by agonists |
6 |
5 nM Epinephrine, 5hr |
Ligand, 10 μM |
Kinetics dependent deactivation of the receptor after prolonged activation with epinephrine |
7 |
10 μM ligand, 5hr |
Propranolol, 10 μM |
Relative potency, kinetics dependent agonism |
8 |
0.1% DMSO, 1hr |
Forskolin 10 μM |
cAMP-PKA pathway |
|
|
Ligand, 10 μM |
|
9 |
400 ng/ ml cholera toxin, 20hr |
Ligand, 10 μM |
Gαs-dependent and independent activity |
10 |
100 ng/ml pertussis toxin, 20hr |
Ligand, 10 μM |
Gαi sensitivity |
11 |
10 μM TBB, 1hr |
Ligand, 10 μM |
CK2 sensitivity |
12 |
10 μM U0126, 1hr |
Ligand, 10 μM |
MEK1/2 sensitivity |